Beta Drugs Ltd
BSE:
NSE:BETA
BETA Share Price
NSE:BETA
Pharmaceuticals
Small Cap
₹-
0 (0%)
Market Cap
₹1,746.91Cr
PE Ratio
47.94
Beta Drugs Ltd Performance
▲
▲
▲
▲
Beta Drugs Ltd Fundamentals
Beta Drugs Ltd Delivery and Volume
About Beta Drugs Ltd
Beta Drugs Limited was incorporated as a private limited company with the name 'Beta Drugs Private limited' at Himachal Pradesh on September 21, 2005. Subsequently, the company was converted in to public limited company and the name of the company was changed to 'Beta Drugs Limited' on August 11, 20
| Name | Designation |
|---|---|
| Balwant Singh. | Whole-time Director |
| Varun Batra | Joint Managing Director |
| Rahul Batra | Chairperson & M D |
| Manmohan Khanna | Independent Director |
| Rohit Parti | Independent Director |
| Rajni Brar | Company Sec. & Compli. Officer |
| Ashutosh Shukla | Whole-time Director |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Beta Drugs Ltd FAQs
How do I Buy Beta Drugs Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Beta Drugs Ltd shares in BlinkX.
What is the Share Price of Beta Drugs Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Beta Drugs Ltd's share price is ₹1730.55 as of 2025-05-11.
What is the PE ratio of Beta Drugs Ltd?
Beta Drugs Ltd's P/E ratio is 47.94 times as of 2025-05-11.
What is the PB ratio of Beta Drugs Ltd?
Beta Drugs Ltd's most recent financial reports indicate a price-to-book ratio of 11.12, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Beta Drugs Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Beta Drugs Ltd's market capitalization is ₹1746.91 Cr as on 2025-05-11.
What is the ROE of Beta Drugs Ltd?
The current financial records of Beta Drugs Ltd show a -% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Beta Drugs Ltd?
According to Beta Drugs Ltd's most recent financial filings, the company has a total asset value of ₹114.49, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Beta Drugs Ltd?
The 52-week high/low price of a Beta Drugs Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Beta Drugs Ltd's 52-week high and low as of 2025-05-11 are ₹1738.95 and ₹1673.5, respectively.
